Alpha Tau Medical

OverviewSuggest Edit

Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. The Company's therapy treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha-emitting atoms into the tumor.

TypePrivate
Founded2016
HQTel Aviv-Yafo, IL
Websitealphatau.com

Latest Updates

Employees (est.) (Apr 2021)58(-3%)
Cybersecurity ratingAMore

Alpha Tau Medical Office Locations

Alpha Tau Medical has offices in Tel Aviv-Yafo and Boston
Tel Aviv-Yafo, IL (HQ)
School of Physics
Boston, MA, US
8 Faneuil Hall Marketplace, 3rd Floor
Show all (2)

Alpha Tau Medical Financials and Metrics

Summary Metrics

Founding Date

2016

Alpha Tau Medical total Funding

$55 m

Alpha Tau Medical latest funding size

$26 m

Time since last funding

a year ago

Alpha Tau Medical investors

Alpha Tau Medical's latest funding round in June 2020 was reported to be $26 m. In total, Alpha Tau Medical has raised $55 m
Show all financial metrics

Alpha Tau Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Alpha Tau Medical Online and Social Media Presence

Embed Graph

Alpha Tau Medical News and Updates

Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer

TEL AVIV, Israel, March 26, 2019 /PRNewswire/ -- Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that Mr. Raphi Levy will be joining Alpha Tau's management team as Chief Financial Officer. Mr. Levy will focus primarily on...

Alpha Tau Medical Blogs

Israeli medical device maker Alpha Tau raises $26 million to fund trials

JERUSALEM (Reuters) - Israeli medical device maker Alpha Tau Medical said on Thursday it raised $26 million in a funding round from investors including Shavit Capital, Medison Ventures and OurCrowd to help finance global clinical trials.Alpha Tau said it has successfully completed its first-in-human…

Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round

Tel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million. Investors in the round included a mix of existing investors from previous rounds, such as Sha…

Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT

Introduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a friend of hers, she had just received her third diagnosis of cancer in multiple organs, as part of a long journey that had started in 2013.Lela’s Cancer Treatment …

Alpha Tau Medical Announces Exclusive Distribution Arrangement with Medison Canada For Breakthrough Cancer Treatment Alpha DaRT

Tel Aviv, Israel -- Alpha Tau Medical – the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, and Medison Canada – a fully owned subsidiary of Medison Pharma, are pleased to announce that they have entered into an exclusive distribution arrangement.Medison is a specialized pharmac…

The Introduction of Alpha DaRT in Russia for Treatment of Metastatic Breast Cancer

On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in Obninsk, in a patient diagnosed with metastatic breast cancer. Radiation Oncologist Dr. Razvan Galalae from Essen, Germany, performed the treatment with the support of…

How Israeli technology saved 78-year-old Leah from skin cancer

In August 2018, Jonathan and Na’ama Ellman, an Israeli couple living in the United States, brought their two-year-old son Ari to the emergency room for uncontrolled vomiting. Their whole world seemed to shatter when the doctors realized that the problem was caused by a large tumor in the lower part …
Show more

Alpha Tau Medical Frequently Asked Questions

  • When was Alpha Tau Medical founded?

    Alpha Tau Medical was founded in 2016.

  • How many employees does Alpha Tau Medical have?

    Alpha Tau Medical has 58 employees.

  • Who are Alpha Tau Medical competitors?

    Competitors of Alpha Tau Medical include Sensei Biotherapeutics, Notch Therapeutics and JW Therapeutics.

  • Where is Alpha Tau Medical headquarters?

    Alpha Tau Medical headquarters is located at School of Physics, Tel Aviv-Yafo.

  • Where are Alpha Tau Medical offices?

    Alpha Tau Medical has offices in Tel Aviv-Yafo and Boston.

  • How many offices does Alpha Tau Medical have?

    Alpha Tau Medical has 2 offices.